Zentalis Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Zentalis Pharmaceuticals, Inc.
CIK #0001725160
EDGAR Form CIK 2011 - 2025
10-K [0001725160]
10-Q [0001725160]
3 [0001725160]
4 [0001725160]
8-K [0001725160]
D [0001725160]
SC 13D [0001725160]
SC 13G [0001725160]
Form 13D/13G Filer Form 13D/13G Subject Filed
Millennium Management LLC Zentalis Pharmaceuticals Inc [2025-02-04]
Walters William T Zentalis Pharmaceuticals Inc [2024-12-10]
Citadel Advisors LLC Zentalis Pharmaceuticals Inc [2023-11-17]
Eventide Asset Management LLC Zentalis Pharmaceuticals Inc [2023-10-10]
Tybourne Capital Management HK Ltd Zentalis Pharmaceuticals Inc [2023-02-14]
Capital International Investors Zentalis Pharmaceuticals Inc [2023-02-13]
State Street Corp Zentalis Pharmaceuticals Inc [2023-02-07]
Wellington Management Group LLP Zentalis Pharmaceuticals Inc [2023-02-06]
Matrix Capital Management Company LP Zentalis Pharmaceuticals Inc [2022-06-03]
Price T Rowe Associates Inc /MD/ Zentalis Pharmaceuticals Inc [2022-02-14]
View All
Form 3/4/5 Subject 2011 - 2025
Johnson David Michael
Zentalis Pharmaceuticals, Inc.
Walker Luke Nathaniel
Skvarka Jan
Kariuki Enoch
Myers Scott Dunseth
Bruns Ingmar
Lackner Mark
Vultaggio Vincent
Paul Andrea
Eastland Julia Marie
Gallagher Cam
Hausman Diana
Epperly Melissa B,
Blackwell Kimberly
Bunker Kevin D.
Brownstein Carrie
Matrix Capital Management Company, LP
GOEL David E
Roth Iris
Sun Anthony Y
Voliotis Dimitris
Pinto Alexis
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities Illiquid Investments Sub-Master
Halvorsen Ole Andreas
Ott David C.
Shabet Rose Sharon
Viking Global Opportunities GP LLC
Viking Global Investors LP
Recurium Equity, LLC
Takhar Karan S.
Terms | Privacy | Guide
tony@aum13f.com